Interestingly, molecular analysis review conducted on tumor samples with the new v12.3 classifier showed a match with pediatric RTK1 type, subtype B, and a complex copy number variation (CNV) with CDK6 and MET amplification, and a platelet-derived growth factor A (PDGFRA) gain. Here, MET is linked to neoplasm.